Mariko Shimamura

1.9k total citations
58 papers, 1.5k citations indexed

About

Mariko Shimamura is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mariko Shimamura has authored 58 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 17 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Mariko Shimamura's work include Angiogenesis and VEGF in Cancer (17 papers), Neuropeptides and Animal Physiology (16 papers) and Peptidase Inhibition and Analysis (11 papers). Mariko Shimamura is often cited by papers focused on Angiogenesis and VEGF in Cancer (17 papers), Neuropeptides and Animal Physiology (16 papers) and Peptidase Inhibition and Analysis (11 papers). Mariko Shimamura collaborates with scholars based in Japan, United States and United Kingdom. Mariko Shimamura's co-authors include Tsutomu Oikawa, Tadahiko Hazato, Takao Iwaguchi, Yukio Yamamoto, Hiromi Ashino, Hitoshi Hori, Hideko Nagasawa, Yoshihiro Uto, Masaaki Iigo and Keiji Tanaka and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and Brain Research.

In The Last Decade

Mariko Shimamura

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariko Shimamura Japan 24 826 353 251 192 168 58 1.5k
Réjean Ruel Canada 19 1.4k 1.7× 310 0.9× 152 0.6× 315 1.6× 131 0.8× 32 2.4k
Kunitaka Hirose Japan 22 883 1.1× 421 1.2× 241 1.0× 574 3.0× 81 0.5× 34 1.8k
Antonina Azzolina Italy 28 916 1.1× 201 0.6× 229 0.9× 416 2.2× 100 0.6× 53 2.0k
Barbara G. Heerdt United States 23 1.3k 1.6× 571 1.6× 381 1.5× 200 1.0× 122 0.7× 36 2.1k
Arkadiusz Surażyński Poland 26 951 1.2× 715 2.0× 606 2.4× 143 0.7× 240 1.4× 105 2.2k
Anders Wetterholm Sweden 23 660 0.8× 310 0.9× 95 0.4× 284 1.5× 108 0.6× 49 1.7k
Tomohisa Yokoyama Japan 22 1.1k 1.3× 450 1.3× 269 1.1× 176 0.9× 40 0.2× 44 2.0k
Thomas A. Rano United States 12 1.8k 2.2× 365 1.0× 212 0.8× 419 2.2× 122 0.7× 15 2.4k
Baskaran Govindarajan United States 21 1000 1.2× 412 1.2× 221 0.9× 276 1.4× 83 0.5× 26 1.8k
Angel L. Armesilla United Kingdom 30 1.6k 2.0× 507 1.4× 416 1.7× 286 1.5× 123 0.7× 50 2.8k

Countries citing papers authored by Mariko Shimamura

Since Specialization
Citations

This map shows the geographic impact of Mariko Shimamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Shimamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Shimamura more than expected).

Fields of papers citing papers by Mariko Shimamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Shimamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Shimamura. The network helps show where Mariko Shimamura may publish in the future.

Co-authorship network of co-authors of Mariko Shimamura

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Shimamura. A scholar is included among the top collaborators of Mariko Shimamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Shimamura. Mariko Shimamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Motomu, Mariko Shimamura, Toshiyuki Owaki, et al.. (2006). Antiangiogenic and Antitumor Activities of IL-27. The Journal of Immunology. 176(12). 7317–7324. 145 indexed citations
2.
Yamamoto, Yukio, Yoshiko Akita, Teruhide Yamaguchi, et al.. (2005). Two-dimensional electrophoretic analysis of disease-associated proteins in human cerebrospinal fluid from patients with rheumatoid arthritis. 49(1). 23–27. 1 indexed citations
3.
Jin, Chengzhe, Hideko Nagasawa, Mariko Shimamura, et al.. (2004). Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers. Bioorganic & Medicinal Chemistry. 12(18). 4917–4927. 22 indexed citations
4.
Ashino, Hiromi, Mariko Shimamura, Hiroshi Nakajima, et al.. (2003). Novel Function of Ascorbic Acid as an Angiostatic Factor. Angiogenesis. 6(4). 259–269. 74 indexed citations
6.
Yamamoto, Yurie, et al.. (2002). Spinorphin as an Endogenous Inhibitor of Enkephalin-degrading Enzymes: Roles in Pain and Inflammation. Current Protein and Peptide Science. 3(6). 587–599. 31 indexed citations
7.
Yamamoto, Yukio, Junichi Hashimoto, Mariko Shimamura, Teruhide Yamaguchi, & Tadahiko Hazato. (2000). Characterization of tynorphin, a potent endogenous inhibitor of dipeptidyl peptidaseIII. Peptides. 21(4). 503–508. 37 indexed citations
9.
Yamaji, Taketo, Masayuki Uchida, Eiichi Sugino, et al.. (1999). Anti-angiogenic activity of a novel synthetic agent, 9 α -fluoromedroxyprogesterone acetate. Cancer Letters. 145(1-2). 107–114. 10 indexed citations
10.
Oikawa, Tsutomu, Toru Sasaki, Masaki Nakamura, et al.. (1998). The Proteasome Is Involved in Angiogenesis. Biochemical and Biophysical Research Communications. 246(1). 243–248. 111 indexed citations
11.
Oikawa, Tsutomu, Maiko Sasaki, Mariko Shimamura, et al.. (1997). Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo.. PubMed. 17(3C). 1881–6. 66 indexed citations
12.
Shimamura, Mariko, et al.. (1997). Inhibition of Angiogenesis by Rhizoxin, a Microbial Metabolite Containing Two Epoxide Groups. Japanese Journal of Cancer Research. 88(12). 1125–1129. 14 indexed citations
13.
Sugino, Eiichi, Satoshi Hibino, Tominari Choshi, et al.. (1997). Synthesis of a New Potent Anti-angiogenic Agent, 17.ALPHA.-Acetoxy-9.ALPHA.-fluoro-6.ALPHA.-methylprogesterone (9.ALPHA.-Fluoromedroxyprogesterone acetate(FMPA)).. Chemical and Pharmaceutical Bulletin. 45(2). 421–423. 7 indexed citations
15.
Oikawa, Tsutomu & Mariko Shimamura. (1996). Potent inhibition of angiogenesis by wortmannin, a fungal metabolite. European Journal of Pharmacology. 318(1). 93–96. 19 indexed citations
16.
Yamamoto, Yukio, et al.. (1993). Angiotensin III Is a New Chemoattractant for Polymorphonuclear Leukocytes. Biochemical and Biophysical Research Communications. 193(3). 1038–1043. 15 indexed citations
17.
Oikawa, Tsutomu, et al.. (1992). Okadaic Acid Is a Potent Angiogenesis Inducer. Japanese Journal of Cancer Research. 83(1). 6–9. 11 indexed citations
18.
Oikawa, Tsutomu, Mariko Shimamura, Osamu Nakamura, et al.. (1992). Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor.. The Journal of Antibiotics. 45(7). 1155–1160. 44 indexed citations
19.
Oikawa, Tsutomu, et al.. (1989). Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).. The Journal of Antibiotics. 42(7). 1202–1204. 37 indexed citations
20.
Shimamura, Mariko, et al.. (1985). Partial purification of two distinct enkephalin-degrading aminopeptidases from human cerebrospinal fluid.. PubMed. 10(5). 813–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026